Correction: SIRT5-modified human umbilical cord mesenchymal stem cells loaded with antioxidant polydopamine nanozyme enhance parpi resistance in ovarian cancer via fatty acid metabolism reprogramming | Synapse
March 3, 2026Open Access
Correction: SIRT5-modified human umbilical cord mesenchymal stem cells loaded with antioxidant polydopamine nanozyme enhance parpi resistance in ovarian cancer via fatty acid metabolism reprogramming
Key Points
PARPi resistance is enhanced through metabolic reprogramming involving fatty acid metabolism, leading to improved treatment outcomes.
SIRT5-modified mesenchymal stem cells were loaded with antioxidant polydopamine nanozyme to facilitate this resistance.
The assessment used advanced cellular techniques to evaluate the impact of these modifications on ovarian cancer cells.
Through this approach, potential new treatment strategies may be developed to combat ovarian cancer more effectively.